Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), alter disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
alter decrease » larger decrease (Expand Search), water decreases (Expand Search), alter disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
2281
-
2282
-
2283
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2284
-
2285
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2286
-
2287
-
2288
-
2289
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2290
-
2291
-
2292
-
2293
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2294
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2295
-
2296
-
2297
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2298
-
2299
-
2300